Skip to content

Clinical trials

Phase 2 Mycobacterium Infections trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Mycobacterium Infections Phase: Phase 2 Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20101
20131
20161
20181
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Enrolling by invitation1
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Allergy and Infectious Diseases (NIAID)2
Beijing Chest Hospital1
Centre Hospitalier Universitaire, Amiens1
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation1
InterMune1
Kevin Winthrop1
Lisichansk Regional Tuberculosis Dispensary1
National Center for Research Resources (NCRR)1
National Jewish Health1
Otsuka Pharmaceutical Development & Commercialization, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Mycobacterium Infections11
Tuberculosis4
Bacterial Infections3
Mycobacterium avium-intracellulare Infection3
Communicable Diseases2
Immune System Diseases2
Mycobacterium Infections, Nontuberculous2
Pneumonia2
Rare Diseases2
Tuberculosis, Multidrug-Resistant2

Trials

Showing 51 to 11 of 11. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.